Related by context. Frequent words. (Click for all words.) 76 Drug Candidate 76 Meets Primary Endpoint 75 Receives Orphan Drug Designation 73 Initiates Phase II 73 Improves Survival 72 Significantly Improves 72 Patient Enrollment 72 Completes Enrollment 72 Study Demonstrates 71 Phase III Clinical Trial 71 FDA Clears 71 Drug Shows Promise 71 Pivotal Phase III 71 Phase III Trial 71 Pivotal Phase 71 Single Dose 71 Presents Positive 71 FDA Accepts 70 Pediatric Patients 70 Patients Undergoing 70 Clinical Trial Results 70 Recombinant Human 70 Renal Cell Carcinoma 70 Commences Phase 70 Generic Version 70 Initiate Phase 69 Announces FDA Clearance 69 Atopic Dermatitis 69 Significantly Improved 69 Significantly Reduces 69 Pivotal Trial 69 Diabetic Neuropathy 69 Metastatic Melanoma 69 Meta Analysis 69 Develop Novel 69 J Am Coll 69 Heart Failure Patients 69 Elderly Patients 69 Preclinical Data 69 Pivotal Study 68 Shows Promise 68 Epidermal Growth Factor Receptor 68 Patients Treated 68 Receives FDA Clearance 68 Reduces Risk 68 Monoclonal Antibody 68 Initiates Phase 68 Panzem R 68 Combination Therapy 68 Kuvan R 67 Inhibits 67 Low Dose 67 Antifungal 67 Denufosol 67 Benign Prostatic Hyperplasia 67 refractory chronic lymphocytic 67 Chronic Heart Failure 67 Aliskiren 67 Anti Inflammatory 67 Eculizumab 66 Epratuzumab 66 Well Tolerated 66 Gene Mutation 66 Bevacizumab 66 #-# Full Text 66 Coadministration 66 Irinotecan 66 Arthritis Drug 66 Lubiprostone 66 Myelodysplastic Syndromes 66 Tacrolimus 66 II Clinical Trial 66 Significantly Reduced 66 Chronic Hepatitis C 66 Metastatic Colorectal Cancer 66 CHEAP ONLINE PHARMACY LOW 65 Osteoporosis Drug 65 gets USFDA nod 65 Diagnostic Tests 65 Increases Risk 65 Tumor Growth 65 Monotherapy 65 Prostate Cancer Patients 65 Post Operative 65 liposomal formulation 65 Induces 65 Patent Covering 65 Kepivance 65 Lung Cancer Patients 65 MKC# 65 Dasatinib 65 Golimumab 65 Overactive Bladder 65 Acute Ischemic Stroke 65 Am J Clin 65 Drug Resistant 65 Tesetaxel 64 Myelofibrosis 64 J Am Acad 64 R sorafenib tablets 64 Bioavailability